Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: A meta-analysis of individual data in 294 patients

Journal of Hypertension

Volumn 29, Issue 6, 2011, Pages 1034-1042

  Ong, Kim Thanh ^a,b,c   Delerme, Samuel ^d   Pannier, Bruno ^b,e   Safar, Michel E ^c,f   Benetos, Athanase ^g   Laurent, Stéphane ^a,b,c   Boutouyrie, Pierre ^a,b,c  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Centre Hospitalier MH Manhes   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

antihypertensive treatments; arterial stiffness; hypertension; meta analysis

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CADRALAZINE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; HYDROCHLOROTHIAZIDE; IRBESARTAN; ISRADIPINE; LACIDIPINE; LISINOPRIL; NITRENDIPINE; PLACEBO; QUINAPRIL; RAMIPRIL; TRANDOLAPRIL;

ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CIGARETTE SMOKING; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DYSLIPIDEMIA; ESSENTIAL HYPERTENSION; HEART HEMODYNAMICS; HEART RATE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 79955605417     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328346a583     Document Type: Article

References (63)

1. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 1994; 140:669-682. (Pubitemid 24322180)
2. Laurent S, Cockcroft J, Van BL, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605. (Pubitemid 44627304)
3. Mahmud A, Feely J. Antihypertensive drugs and arterial stiffness. Expert Rev Cardiovasc Ther 2003; 1:65-78.
4. Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D. Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension 2010; 55:333-338.
5. Kass DA, Shapiro EP, Kawaguchi M, et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001; 104:1464-1470. (Pubitemid 32917336)
6. Whitehead A, Whitehead J. A general parametric approach to the metaanalysis of randomized clinical trials. Stat Med 1991.
7. Pannier BM, Lafleche AB, Girerd XJ, London GM, Safar ME. Arterial stiffness and wave reflections following acute calcium blockade in essential hypertension. Am J Hypertens 1994; 7:168-176. (Pubitemid 24079127)
8. Topouchian J, Brisac AM, Pannier B, Vicaut E, Safar M, Asmar R. Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover study. J Hum Hypertens 1998; 12:181-187. (Pubitemid 28140288)
9. Asmar RG, Benetos A, Darne BM, Pauly NC, Safar ME. Converting enzyme inhibition: dissociation between antihypertensive and arterial effects. J Hum Hypertens 1992; 6:381-385.
10. Benetos A, Gautier S, Lafleche A, et al. Blockade of angiotensin II type 1 receptors: effect on carotid and radial artery structure and function in hypertensive humans. J Vasc Res 2000; 37:8-15. (Pubitemid 30158036)
11. Benetos A, Lafleche A, Asmar R, Gautier S, Safar A, Safar ME. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension. J Hum Hypertens 1996; 10:77-82. (Pubitemid 26101028)
12. Asmar RG, Benetos A, Chaouche-Teyara K, Raveau-Landon CM, Safar ME. Comparison of effects of felodipine versus hydrochlorothiazide on arterial diameter and pulse-wave velocity in essential hypertension. Am J Cardiol 1993; 72:794-798. (Pubitemid 23291939)
13. Benetos A, Cambien F, Gautier S, et al. Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension 1996; 28:1081-1084. (Pubitemid 26415828)
14. Lafleche A, Gautier S, Topouchian J, et al. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension. Clin Pharmacol Ther 1998; 64:96-105. (Pubitemid 28377335)
15. Benetos A, Xiao YY, Cuche JL, Hannaert P, Safar M. Arterial effects of salt restriction in hypertensive patients. A 9-week, randomized, double-blind, crossover study. J Hypertens 1992; 10:355-360.
16. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010.
17. Asmar R, Benetos A, London G, et al. Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Press 1995; 4:48-54.
18. Ait Oufella H, Collin C, Bozec E, et al. Long term reduction in aortic stiffness: a 5.3 years follow-up in routine clinical practice. J Hypertens 2010.
19. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33:1111-1117. (Pubitemid 29230958)
20. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39:10-15. (Pubitemid 34098081)
21. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241. (Pubitemid 34163575)
22. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99:2434-2439. (Pubitemid 29218240)
23. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106:2085-2090. (Pubitemid 35192814)
24. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well functioning older adults. Circulation 2005; 111:3384-3390. (Pubitemid 40923391)
25. Asmar RG, Pannier B, Santoni JP, et al. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 1988; 78:941-950.
26. Tropeano AI, Boutouyrie P, Pannier B, et al. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension 2006; 48:80-86. (Pubitemid 44313590)
27. Mitchell GF, Dunlap ME, Warnica W, et al. Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension 2007; 49:1271-1277. (Pubitemid 46809368)
28. Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y. A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. Adv Perit Dial 2003; 19:59-66.
29. Safar ME, LondonGM, Bouthier JA, Levenson JA, Laurent S. Brachial artery cross-sectional area and distensibility before and after arteriolar vasodilatation in men with sustained essential hypertension. J Cardiovasc Pharmacol 1987; 9:734-742. (Pubitemid 17095577)
30. Safar ME, Pannier B, Laurent S, London GM. Calcium-entry blockers and arterial compliance in hypertension. J Cardiovasc Pharmacol 1989; 14 (Suppl 10):S1-S6. (Pubitemid 20109711)
31. Dhakam Z, Yasmin, McEniery CM, Burton T, Brown MJ, Wilkinson IB. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens 2008; 26:351-356.
32. Kool MJ, Lustermans FA, Breed JG, et al. The influence of perindopril and the diuretic combination amiloride\+hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients. J Hypertens 1995; 13:839-848.
33. Brewster UC, Setaro JF, Perazella MA. The renin-angiotensin- aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci 2003; 326:15-24. (Pubitemid 36870293)
34. Struthers AD, MacDonald TM. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc Res 2004; 61:663-670. (Pubitemid 38249465)
35. Heagerty AM, Bund SJ, Aalkjaer C. Effects of drug treatment on human resistance arteriole morphology in essential hypertension: direct evidence for structural remodelling of resistance vessels. Lancet 1988; 2:1209-1212.
36. Mahmud A, Feely J. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens 2008; 21:663-667. (Pubitemid 351733365)
37. Pannier B, Guerin A, London G, Asmar R, Safar M. [Combination of lowdose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study]. Arch Mal Coeur Vaiss 2002; 95(Spec No. 6):11-16.
38. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressurelowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225.
39. Boutouyrie P, Achouba A, Trunet P, Laurent S. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study. Hypertension 2010; 55:1314-1322.
40. Albaladejo P, Asmar R, Safar M, Benetos A. Association between 24-h ambulatory heart rate and arterial stiffness. J Hum Hypertens 2000; 14:137-141. (Pubitemid 30110448)
41. Sa CR, Pannier B, Benetos A, et al. Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens 1997; 15 (12 Pt 1):1423-1430. (Pubitemid 28039570)
42. Palatini P, Benetos A, Grassi G, et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006; 24:603-610.
43. Safar ME. Pulse pressure in essential hypertension: clinical and therapeutical implications. J Hypertens 1989; 7:769-776. (Pubitemid 19281809)
44. Millar JA, Lever AF, Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens 1999; 17:1065-1072. (Pubitemid 29389552)
45. Benetos A, Safar M, Rudnichi A, et al. Pulse pressure: a predictor of longterm cardiovascular mortality in a French male population. Hypertension 1997; 30:1410-1415. (Pubitemid 27528083)
46. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation 1999; 100:354-360. (Pubitemid 29362404)
47. Assmann G, Cullen P, Evers T, Petzinna D, Schulte H. Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. Eur Heart J 2005; 26:2120-2126. (Pubitemid 41407994)
48. Mitchell GF, Moye LA, Braunwald E, et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. Circulation 1997; 96:4254-4260. (Pubitemid 28007452)
49. Domanski M, Norman J, Wolz M, Mitchell G, Pfeffer M. Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension 2001; 38:793-797. (Pubitemid 34258672)
50. Panagiotakos DB, Kromhout D, Menotti A, et al. The relation between pulse pressure and cardiovascular mortality in 12 763 middle-aged men from various parts of the world: a 25-year follow-up of the seven countries study. Arch Intern Med 2005; 165:2142-2147. (Pubitemid 41434591)
51. Gasowski J, Fagard RH, Staessen JA, et al. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J Hypertens 2002; 20:145-151. (Pubitemid 34913414)
52. Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007; 50:197-203. (Pubitemid 46986041)
53. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and largeartery remodeling. Circulation 1999; 100:1387-1393. (Pubitemid 29451697)
54. Kailasam MT, Parmer RJ, Cervenka JH, et al. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension 1995; 26:143-149.
55. Boutouyrie P, Lacolley P, Girerd X, Beck L, Safar M, Laurent S. Sympathetic activation decreases medium-sized arterial compliance in humans. Am J Physiol 1994; 267 (4 Pt 2):H1368-H1376.
56. Joannides R, Richard V, Moore N, Godin M, Thuillez C. Influence of sympathetic tone on mechanical properties of muscular arteries in humans. Am J Physiol 1995; 268 (2 Pt 2):H794-H801.
57. Ahimastos AA, Natoli AK, Lawler A, Blombery PA, Kingwell BA. Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertension 2005; 45:1194-1199. (Pubitemid 40770326)
58. Fiad TM, Cunningham SK, Hayes FJ, McKenna TJ. Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis. J Clin Endocrinol Metab 1997; 82:457-460. (Pubitemid 27068611)
59. Ledingham JM, Hamada M, Simpson FO. Effect of felodipine on blood pressure, body sodium, plasma renin activity and plasma aldosterone in hypertensive and normotensive rats. Clin Exp Pharmacol Physiol Suppl 1995; 22:S323-S325. (Pubitemid 26062118)
60. Boutouyrie P, Bussy C, Hayoz D, et al. Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation 2000; 101:2601-2606. (Pubitemid 30350638)
61. Kahonen M, Ylitalo R, Koobi T, Turjanmaa V, Ylitalo P. Influences of nonselective, beta(1)-selective and vasodilatory beta(1)-selective betablockers on arterial pulse wave velocity in normotensive subjects. Gen Pharmacol 2000; 35:219-224. (Pubitemid 34119413)
62. Flather MD, Farkouh ME, Pogue JM, Yusuf S. Strengths and limitations of meta-analysis: larger studies may be more reliable. Control Clin Trials 1997; 18:568-579. (Pubitemid 27521695)
63. Benetos A, Adamopoulos C, Bureau JM, et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002; 105:1202-1207. (Pubitemid 34225821)